Literature DB >> 24068578

The Asia Pacific meeting on vasculitis and ANCA 2012 workshop on Takayasu arteritis: advances in diagnosis and medical treatment.

Mitsuaki Isobe1.   

Abstract

Takayasu arteritis is a rare disease affecting especially young females. Nonspecific symptoms make the diagnosis difficult; cases in which a diagnosis has not been made for a long period are not rare. However, recent progress in imaging modalities including magnetic resonance angiography, computed tomography angiography, and positron emission tomography have allowed making specific diagnoses in the early stage. Although specific serological markers of this disease are not known, many biomarkers specific to arterial inflammation are being developed and applied for diagnosing this disease. Also, advances in immunosuppressive treatment including new biological agents could alter the clinical outcome of the disease. According to these changes in diagnosis and treatment, the prognosis of Takayasu arteritis has been improving.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068578     DOI: 10.1007/s10157-012-0697-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

1.  New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis.

Authors:  Chisato Takamura; Hirokazu Ohhigashi; Yusuke Ebana; Mitsuaki Isobe
Journal:  Circ J       Date:  2012-05-16       Impact factor: 2.993

2.  Improved prognosis of Takayasu arteritis over the past decade--comprehensive analysis of 106 patients.

Authors:  Hirokazu Ohigashi; Go Haraguchi; Masanori Konishi; Daisuke Tezuka; Tetsuo Kamiishi; Takashi Ishihara; Mitsuaki Isobe
Journal:  Circ J       Date:  2012-02-02       Impact factor: 2.993

3.  Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.

Authors:  Kathleen Maksimowicz-McKinnon; Tiffany M Clark; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2007-03

4.  Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker.

Authors:  Takashi Ishihara; Go Haraguchi; Tetsuo Kamiishi; Daisuke Tezuka; Hiroshi Inagaki; Mitsuaki Isobe
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

5.  Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society.

Authors: 
Journal:  Circ J       Date:  2011-01-20       Impact factor: 2.993

6.  Pentraxin-3 as a marker of disease activity in Takayasu arteritis.

Authors:  Lorenzo Dagna; Fulvio Salvo; Mirta Tiraboschi; Enrica P Bozzolo; Stefano Franchini; Claudio Doglioni; Angelo A Manfredi; Elena Baldissera; Maria Grazia Sabbadini
Journal:  Ann Intern Med       Date:  2011-10-04       Impact factor: 25.391

7.  Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.

Authors:  Daisuke Tezuka; Go Haraguchi; Takashi Ishihara; Hirokazu Ohigashi; Hiroshi Inagaki; Jun-ichi Suzuki; Kenzo Hirao; Mitsuaki Isobe
Journal:  JACC Cardiovasc Imaging       Date:  2012-04

8.  Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity.

Authors:  Maurizio Papa; Francesco De Cobelli; Elena Baldissera; Lorenzo Dagna; Elena Schiani; Mariagrazia Sabbadini; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

9.  Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.

Authors:  Norihiro Nishimoto; Hideko Nakahara; Naoko Yoshio-Hoshino; Toru Mima
Journal:  Arthritis Rheum       Date:  2008-04

10.  Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.

Authors:  E S Molloy; C A Langford; T M Clark; C E Gota; G S Hoffman
Journal:  Ann Rheum Dis       Date:  2008-08-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.